HCA Healthcare, Inc. $HCA Shares Sold by GC Wealth Management RIA LLC

Key Points

• GC Wealth Management RIA LLC cut its stake in HCA Healthcare by 76.2% in Q4, selling 3,170 shares and leaving 989 shares valued at $462,000, while institutional investors now hold about 62.73% of the stock.
• Insiders sold a total of 15,214 shares worth approximately $7.8 million last quarter — including EVP Michael R. McAlevey and SVP Christopher F. Wyatt — and corporate insiders now own about 1.50% of HCA.
• Several analysts (Mizuho, Goldman, UBS) raised price targets and HCA has a consensus rating of Moderate Buy with a $520.55 consensus target; the company reported Q EPS of $7.15 (missed by $0.04) and set FY2026 guidance of 29.10–31.50 EPS.

GC Wealth Management RIA LLC cut its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 76.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 989 shares of the company's stock after selling 3,170 shares during the quarter. GC Wealth Management RIA LLC's holdings in HCA Healthcare were worth $462,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in HCA. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $1,021,000. NewEdge Advisors LLC increased its position in shares of HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company's stock valued at $1,334,000 after buying an additional 409 shares in the last quarter. Sivia Capital Partners LLC increased its position in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock valued at $241,000 after buying an additional 33 shares in the last quarter. Jump Financial LLC purchased a new stake in shares of HCA Healthcare in the second quarter valued at approximately $2,073,000. Finally, Sei Investments Co. increased its position in shares of HCA Healthcare by 56.3% in the second quarter. Sei Investments Co. now owns 136,589 shares of the company's stock valued at $52,328,000 after buying an additional 49,214 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the company's stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the transaction, the executive vice president owned 8,853 shares of the company's stock, valued at $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president directly owned 44,379 shares of the company's stock, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 15,214 shares of company stock valued at $7,797,595 in the last quarter. Corporate insiders own 1.50% of the company's stock.

Analysts Set New Price Targets

Several analysts recently commented on the company. Mizuho boosted their price target on HCA Healthcare from $540.00 to $585.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 25th. Weiss Ratings reiterated a "buy (b)" rating on shares of HCA Healthcare in a research report on Friday, March 27th. The Goldman Sachs Group boosted their price target on HCA Healthcare from $520.00 to $558.00 and gave the stock a "buy" rating in a research report on Wednesday, January 28th. UBS Group boosted their price target on HCA Healthcare from $598.00 to $635.00 and gave the stock a "buy" rating in a research report on Monday, February 23rd. Finally, Sanford C. Bernstein dropped their price target on HCA Healthcare from $541.00 to $503.00 and set a "market perform" rating for the company in a research report on Tuesday. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $520.55.

HCA Healthcare Stock Down 0.2%

Shares of NYSE:HCA opened at $433.73 on Friday. The business has a fifty day moving average of $497.66 and a two-hundred day moving average of $485.41. The stock has a market cap of $96.50 billion, a P/E ratio of 14.92, a PEG ratio of 1.38 and a beta of 1.19. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analysts' expectations of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm's quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 30.05 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.